Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Urease is a nickel-containing metalloenzyme that catalyzes the hydrolysis of urea into ammonia and carbon dioxide. It is found in bacteria, fungi, yeast, and higher plants. In pathogenic bacteria, urease neutralizes gastric acid to facilitate colonization. Antibodies against bacterial ureases can be detected serologically and is used as a diagnostic marker for Helicobacter pylori. It also plays a role in autoimmune responses.
Urea binds at the bi-nickel center via its carbonyl oxygen. Nickel ions polarize urea’s carbonyl group. Hydrolysis yields carbamate and ammonia; carbamate spontaneously decomposes into another molecule of ammonia plus CO₂ at physiological pH
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Urease (None).